Swiss National Bank Fibrogen Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$2.49 - $20.59 $5,478 - $45,298	2,200 Added 1.14%	194,800 $525,000
Q1 2023 May 10, 2023	SELL	$15.95 - $25.18 $357,280 - $564,032	-22,400 Reduced 10.42%	192,600 $3.59 Million
Q4 2022 Feb 08, 2023	BUY	$13.27 - $17.73 $63,696 - $85,104	4,800 Added 2.28%	215,000 $3.44 Million
Q3 2022 Nov 09, 2022	BUY	$11.4 - $14.6 $30,780 - $39,420	2,700 Added 1.3%	210,200 $2.74 Million
Q2 2022 Aug 09, 2022	BUY	$7.94 - $12.96 $80,988 - $132,192	10,200 Added 5.17%	207,500 $2.19 Million
Q1 2022 May 09, 2022	BUY	$12.02 - $16.79 $169,482 - $236,739	14,100 Added 7.7%	197,300 $2.37 Million
Q3 2021 Nov 08, 2021	BUY	$10.18 - $26.64 $27,486 - $71,928	2,700 Added 1.5%	183,200 $1.87 Million
Q2 2021 Aug 06, 2021	SELL	$18.57 - $35.68 $122,562 - $235,488	-6,600 Reduced 3.53%	180,500 $4.81 Million
Q1 2021 May 07, 2021	BUY	$31.0 - $55.72 $99,200 - $178,304	3,200 Added 1.74%	187,100 $6.49 Million
Q4 2020 Feb 05, 2021	BUY	$37.09 - $48.97 $77,889 - $102,837	2,100 Added 1.16%	183,900 $6.82 Million
Q3 2020 Nov 09, 2020	BUY	$40.47 - $45.5 $267,102 - $300,300	6,600 Added 3.77%	181,800 $7.48 Million
Q2 2020 Aug 05, 2020	BUY	$32.57 - $42.83 $745,853 - $980,807	22,900 Added 15.04%	175,200 $7.1 Million
Q1 2020 May 08, 2020	BUY	$23.3 - $45.96 $58,250 - $114,900	2,500 Added 1.67%	152,300 $5.29 Million
Q4 2019 Feb 06, 2020	BUY	$34.58 - $48.06 $134,862 - $187,434	3,900 Added 2.67%	149,800 $6.43 Million
Q3 2019 Nov 12, 2019	BUY	$36.98 - $48.45 $96,147 - $125,970	2,600 Added 1.81%	145,900 $5.4 Million
Q2 2019 Aug 02, 2019	BUY	$35.13 - $55.53 $137,007 - $216,567	3,900 Added 2.8%	143,300 $6.47 Million
Q1 2019 May 10, 2019	BUY	$42.83 - $59.91 $222,716 - $311,532	5,200 Added 3.87%	139,400 $7.58 Million
Q4 2018 Feb 13, 2019	BUY	$37.97 - $60.16 $117,707 - $186,496	3,100 Added 2.36%	134,200 $6.21 Million
Q3 2018 Nov 08, 2018	BUY	$56.3 - $67.25 $90,080 - $107,600	1,600 Added 1.24%	131,100 $7.96 Million
Q2 2018 Aug 09, 2018	BUY	$44.9 - $64.95 $368,180 - $532,590	8,200 Added 6.76%	129,500 $8.11 Million
Q1 2018 May 04, 2018	BUY	$45.35 - $61.65 $312,915 - $425,385	6,900 Added 6.03%	121,300 $5.6 Million
Q4 2017 Feb 07, 2018	BUY	$41.95 - $60.1 $75,510 - $108,180	1,800 Added 1.6%	114,400 $5.42 Million
Q3 2017 Nov 03, 2017	BUY	$33.4 - $53.9 $3.76 Million - $6.07 Million	112,600	112,600 $6.06 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account